porno izle
porno
erotik film
asyabahis
women desperate to piss ava addams mom porn sa akin ang gabi

Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the category archives: OBN News

Member Company Press Release

NDY Consulting Ltd: Rui Dinis joins Norman Disney Young to strengthen and drive the work in the Life Sciences Sector.

Norman Disney Young, a global engineering consultancy, is delighted to welcome Rui Dinis to Head the UK Life Sciences Team. Rui has over 20 years working in the Life Sciences sector, successfully developing relationships and opportunities, implementing best practices to ensure compliance and execution of stringent regulatory guidelines in regulated and emerging markets. From startups to long established and leading names in the sector, his proven experience has resulted in significant added value to the clients he worked with.

Read the rest of entry »

Enesi Pharma to Develop Thermostable, Solid Dose DNA Vaccine Targeting Zika Virus under New Partnership with The University of Adelaide

OXFORD, UK – 03 September 2020 – Enesi Pharma (“Enesi”), an innovative biotechnology company developing next-generation vaccination products targeting serious diseases, is delighted to announce its partnership with the University of Adelaide to develop a new thermostable, solid dose DNA vaccine for Zika virus to prevent infection of pregnant women and the resultant congenital effects in the unborn child.

Read the rest of entry »

Yourgene Health: Today announces the launch of IONA® Nx NIPT workflow

Manchester, UK : Yourgene (AIM: YGEN), the international molecular diagnostics group, announced today  the launch of IONA® Nx NIPT workflow, the Company’s new innovative non-invasive prenatal test (‘NIPT’). The IONA Nx seeks to offer clinical labs a high performing, flexible, scalable and innovative NIPT service inhouse and is developed to run on the Illumina Nextseq 550 Dx platform for next generation sequencing.

Read the rest of entry »

Horton International UK: Announce the appointment of Mark Johnson as Senior Partner of its Oxford-based Global Healthcare arm.

Executive search consultancy, Horton International UK, has announced the appointment of Mark Johnson as Senior Partner of its Oxford-based Global Healthcare arm.

Read the rest of entry »

AMSBIO: Optimized Freezing Solutions for Clinical Application of Cell Therapy Products

AMSBIO announce new additions and certifications for their market-leading range of clinical grade, chemically defined cryopreservation excipient solutions - STEM-CELLBANKER® and HSC-BANKER®.

STEM-CELLBANKER® DMSO Free GMP grade is a new chemically defined freezing solution that does not contain DMSO as an anti-freezing agent. It was developed for customers who prefer not to use DMSO-containing cryopreservation solution due to the intended application of the samples. STEM-CELLBANKER® DMSO Free GMP grade is manufactured in compliance with JPN, EU, US, and PIC/S GMP guidelines.

Read the rest of entry »

Vaccitech receives government grant for COVID-19 vaccine research

Oxford, UK: Vaccitech Limited, a clinical-stage biopharmaceutical company developing immunotherapies to treat and prevent infectious diseases and cancer, announces today that it has received a non-dilutive Government grant to support research with its next-generation technology platform to protect against COVID-19. The grant is part of the UKRI-NIHR COVID-19 rapid response rolling call for proposals with potential to deliver public health impacts within 12 months. Preclinical data indicate Vaccitech’s new platform induces leading antibody and cell-mediated immune responses, two arms of the immune system known to protect against disease, when compared with the adenoviral platforms currently in vaccine trials for COVID-19. The preclinical data informed the decision of UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR), and other funders including the World Health Organization (WHO), to support Vaccitech’s research efforts. Vaccitech was awarded £1 ...

Read the rest of entry »

Oxford Nanopore: Nanopore sequencing 101 - online seminar series is back!

The first in the series will be hosted by James Brayer — Associate Director, Market Development, Oxford Nanopore Technologies — on 8th September at 5pm (BST). Join James for an introduction to nanopore sequencing and be sure to bring your questions along for a Q&A which will follow the presentation.

Registration link

AMSBIO: New Cytometry Service Provides Automated Analysis of Fluorescent Biomarkers

AMSBIO announce a new service designed to provide high-content cytometry data on cells and tissues enabling the automated analysis of fluorescent biomarkers on living cells or long-term stored biobanked cells and tissues.  Leveraging the innovative ChipCytometry platform, AMSBIO is able to offer a complete workflow solution (products and services) for high-content cytometry on cells and tissues, from sample preparation and biobanking to biomarker analysis and data mining. The ChipCytometry platform operates by immobilizing cells in microfluidic chips, which are later stained with antibodies for multiplex biomarker detection. Using the ChipCytometry platform - AMSBIO can offer quantitative analysis of a virtually unlimited number of protein biomarkers in a single sample. AMSBIO is also to offer custom assays facilitating analysis of almost any antibody / biomarker target. Not only can this technology deliver quantitative biomarker analysis but it ca ...

Read the rest of entry »

Quotient: The Role of Biopharmaceutics in Early Drug Development - Webinar 6th October

Overcoming challenges for small molecules - webinar Nominated candidates entering clinical development often have sub-optimal physicochemical, biopharmaceutic or DMPK properties for oral delivery. Development teams are challenged with how to understand the properties of new drug candidates, how to design the appropriate formulation strategy and how to move quickly and successfully into early phase clinical trials. Along the way, it is important to identify developability risks and take steps to mitigate these factors, balanced carefully against time and cost investments. This webinar discusses effective strategies being used by biotech and pharmaceutical companies to overcome biopharmaceutic challenges for small molecules in today’s drug development pipeline; and explores alternative approaches for accelerating your early development plan. Speakers: Dr Vanessa Zann, Senior Drug Development Consultant, Quotient Sciences Dr Shriram Pathak, Senior Research Fellow, Scientific ...

Read the rest of entry »

Isansys’ Patient Status Engine named among top 10 healthcare innovations in fight against Covid-19

Oxford, UK: In the Times Future of Healthcare supplement, Isansys’ Patient Status Engine (PSE), a smart clinical data collection, analysis and prediction platform, was acclaimed for playing a crucial role in helping care teams around the world combat the Coronavirus. Using real-time patient data to track the course of the disease, the unique clinical infrastructure aims to improve early detection of Covid-19 – and many other conditions – in patients in hospital and home settings. The PSE uses wearable body-worn sensors to continuously and wirelessly monitor vital signs including heart rate, ECG patterns, respiration rate, blood pressure, temperature and oxygen saturation. Advanced analytic techniques can use these high resolution and highly correlated physiological signals to indicate the presence of the virus, potentially before symptoms are detectable by other methods. These digital biomarkers provide a valuable stream of health data which can enable care teams to better unders ...

Read the rest of entry »

Pages: Previous12NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.